News – Page 378 – Endpoints News

'Rare outliers': Feng Zhang eyes a new path to genetic medicine delivery with ex-Alnylam leaders and $193M

3 years ago

Drug prices 'not justified' by pharma R&D spending, new study says

3 years ago

Over-the-counter Narcan gets unanimous thumbs-up from FDA advisors

3 years ago

The top 100 biotech VCs: Who's staying at the table and what do they want now?

3 years ago

Spain's Grifols to dismiss more than 2,000 US employees in $427M cost savings bid

3 years ago

Asahi Kasei finishes $96M+ pharma excipient manufacturing plant in Japan

3 years ago

Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue

3 years ago

Moderna promises to provide vaccines at no out-of-pocket cost

3 years ago

Thousands of gene and cell therapies are inundating FDA reviewers as the agency tries to keep up

3 years ago

AlloVir unwraps PhII data of cell therapy in expanded transplant indication, leaves trial plans up in the air

3 years ago

ImmunityBio, Codagenix and EuMentis raise funds, while a biotech SPAC dissolves

3 years ago

FDA to review Galera’s drug for radiotherapy complication, biotech immediately seeks $30M

3 years ago

Updated: J&J returns rights to early-stage, RNAi NASH candidate to Arrowhead

3 years ago

Cullinan Oncology drops $25M upfront for candidate from Harbour

3 years ago

Tillman Gerngross’ Amagma Therapeutics quietly ships antibodies to another biotech

3 years ago

Brent Saunders to lead Bausch + Lomb in return to CEO slot

3 years ago

In a first, CMS will test paying less for drugs cleared via accelerated approval

3 years ago

Working its way through a CRL on lead drug, Supernus taps $150M loan

3 years ago

With record-breaking mpox vaccine sales, Bavarian Nordic buys trio of shots from Emergent for $270M cash

3 years ago

Novavax to provide 1.5M more Covid vaccine doses to the US government

3 years ago

A biomanufacturing site is coming to Canada’s Prince Edward Island

3 years ago

FDA revises action on compounded ibuprofen, citing oral version shortage

3 years ago

Law experts argue that abortion drug withdrawal would 'undermine' the approval process

3 years ago

Time to go? Urovant emphasizes quality-of-life concerns in first Gemtesa TV ad

3 years ago

First page Previous page 375 376 377378379 380 381 Next page Last page